Get the Stockscreener App
99.52
4.15%
-4.31
After Hours:
99.52
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $99.52, with a volume of 1.59M.
It is down -4.15% in the last 24 hours and down -2.49% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$103.83
Open:
$102.71
24h Volume:
1.59M
Relative Volume:
1.07
Market Cap:
$11.28B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
42.35
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
-8.27%
1M Performance:
-2.49%
6M Performance:
+12.22%
1Y Performance:
-18.67%
1-Day Range:
$98.89
$104.61
1-Week Range:
$98.89
$109.29
52-Week Range:
$81.36
$123.34
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
99.52 | 11.77B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
542.36 | 212.36B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
215.75 | 155.19B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
643.59 | 51.34B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
129.64 | 37.70B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
180.96 | 34.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026 - News-Medical
Momentum Shift: Is Revvity Inc impacted by rising ratesQuarterly Earnings Report & Short-Term High Return Ideas - baoquankhu1.vn
Revvity (RVTY) Deepens AI And Buybacks Strategy: Is Diagnostics Now Its Core Value Engine? - simplywall.st
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - Yahoo Finance
Revvity (RVTY) Receives a Buy from UBS - The Globe and Mail
Behavioral Patterns of RVTY and Institutional Flows - Stock Traders Daily
Revvity Inc.: How a Quiet Lab-Tech Powerhouse Is Rewiring the Future of Diagnostics and Drug Discove - AD HOC NEWS
Cowen & Co. Maintains Hold on Revvity (RVTY) Feb 03, 2026 - Meyka
Revvity stock price target raised to $124 from $120 at TD Cowen - Investing.com Canada
Revvity stock rating reiterated at Overweight by KeyBanc By Investing.com - Investing.com South Africa
JPMorgan Chase & Co. Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
JP Morgan Raises Revvity (RVTY) Price Target to $105.00 | RVTY S - GuruFocus
Revvity: Close To A Buy, Not Quite There (NYSE:RVTY) - Seeking Alpha
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity (NYSE:RVTY) Shares Track S&P 500 as Index Benchmarks Hold - Kalkine Media
Here's Why Revvity (RVTY) is a Strong Momentum Stock - sharewise.com
Revvity stock price target raised to $124 from $120 at TD Cowen By Investing.com - Investing.com India
TD Cowen Maintains 'Buy' Rating on RVTY, Raises Price Target to $124 | RVTY Stock News - GuruFocus
Revvity (NYSE:RVTY) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Transcript: Q 2026 Earnings Conference Call - Benzinga
Revvity (RVTY) Receives Price Target Boost from Evercore ISI Gro - GuruFocus
Barclays Maintains Overweight Rating on RVTY, Raises Price Targe - GuruFocus
Wells Fargo Raises Price Target for RVTY, Maintains Equal-Weight Rating | RVTY Stock News - GuruFocus
Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
Revvity stock rating reiterated at Overweight by KeyBanc - Investing.com Canada
Wells Fargo & Company Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Revvity (RVTY) Maintains Hold Rating, Price Target Raised to $10 - GuruFocus
Wells Fargo Adjusts Price Target on Revvity to $110 From $107 - marketscreener.com
TD Cowen Adjusts Revvity PT to $124 From $120 - marketscreener.com
Revvity, Inc. (NYSE:RVTY) Q4 2025 earnings call transcript - MSN
Revvity, Inc. (NYSE:RVTY) Q4 2025 Earnings Call Transcript - Insider Monkey
Baird Adjusts Price Target on Revvity to $129 From $123 - marketscreener.com
Raymond James Adjusts Price Target on Revvity to $132 From $115 - marketscreener.com
Evercore ISI Adjusts Price Target on Revvity to $118 From $112 - marketscreener.com
Barclays Adjusts Price Target on Revvity to $118 From $115 - marketscreener.com
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - WHTC
Fund Flows: Whats the beta of Revvity Inc stockMarket Sentiment Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Revvity Q4 2025 slides: EPS beats expectations, stock dips despite strong results - Investing.com Nigeria
Revvity Earnings Call: Solid Execution, Cautious 2026 Outlook - TipRanks
Is Revvity (RVTY) Attractive After Recent Share Price Weakness And DCF Valuation Gap - Yahoo Finance
Revvity: Q4 Earnings Snapshot - KHOU
Revvity Q4 2025 Earnings Call Transcript - MarketBeat
Revvity shares tick up after fourth-quarter results and guidance update - AlphaStreet
Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic ... By GuruFocus - Investing.com Canada
Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic Growth Initiatives - GuruFocus
Revvity, Inc. Provides Revenue Guidance Full Year of 2025 - marketscreener.com
Evercore ISI Raises Revvity Price Target to $118 From $112 - marketscreener.com
Revvity Q4 Earnings Call Highlights - Yahoo Finance
Revvity shares edge higher after fourth-quarter earnings and full-year update - AlphaStreet
Revvity's (NYSE:RVTY) Q4 CY2025 Sales Beat Estimates - Finviz
Revvity (NYSE:RVTY) Shares Track S&P 500 After Corporate Update - Kalkine Media
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):